These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34808091)

  • 1. Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines.
    Adams C; Jadi R; Segovia-Chumbez B; Daag J; Ylade M; Medina FA; Sharp TM; Munoz-Jordan JL; Yoon IK; Deen J; Lopez AL; de Silva AM; Premkumar L
    Emerg Infect Dis; 2021 Dec; 27(12):3073-3081. PubMed ID: 34808091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
    Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
    Emerg Microbes Infect; 2024 Dec; 13(1):2301666. PubMed ID: 38163752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological Evidence of Widespread Zika Transmission across the Philippines.
    Biggs JR; Sy AK; Brady OJ; Kucharski AJ; Funk S; Tu YH; Reyes MAJ; Quinones MA; Jones-Warner W; Ashall J; Avelino FL; Sucaldito NL; Tandoc AO; Cutiongco-de la Paz E; Capeding MRZ; Padilla CD; Hibberd ML; Hafalla JCR
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon.
    Salgado BB; Maués FCJ; Jordão M; Pereira RL; Toledo-Teixeira DA; Parise PL; Granja F; Souza HFS; Yamamoto MM; Chiang JO; Martins LC; Boscardin SB; Lalwani JDB; Vasconcelos PFC; Proença-Modena JL; Lalwani P
    Int J Infect Dis; 2023 Apr; 129():142-151. PubMed ID: 36736575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas.
    Nascimento EJM; Bonaparte MI; Luo P; Vincent TS; Hu B; George JK; Áñez G; Noriega F; Zheng L; Huleatt JW
    Am J Trop Med Hyg; 2019 Sep; 101(3):708-715. PubMed ID: 31392955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue and zika seropositivity, burden, endemicity, and cocirculation antibodies in Nigeria.
    Asaga Mac P; Tadele M; Airiohuodion PE; Nisansala T; Zubair S; Aigohbahi J; Anyaike C; Velayudha R; Kroeger A; Panning M
    Ann Med; 2023 Dec; 55(1):652-662. PubMed ID: 37074313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Rapid Active Sampling Surveys Demonstrated a Rapidly Changing Zika Seroprevalence among Children in a Rural Dengue-endemic Region in Southwest Guatemala during the Zika Epidemic (2015-2016).
    Lamb MM; Paniagua-Avila A; Zacarias A; Rojop N; Chacon A; Natrajan MS; Waggoner JJ; Lopez MR; Cordon-Rosales C; Huleatt JW; Bonaparte MI; Asturias EJ; Olson D
    Am J Trop Med Hyg; 2022 Nov; 107(5):1099-1106. PubMed ID: 36252798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
    Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
    Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
    Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
    Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-based assay discriminates Zika virus infection from other flaviviruses.
    Balmaseda A; Stettler K; Medialdea-Carrera R; Collado D; Jin X; Zambrana JV; Jaconi S; Cameroni E; Saborio S; Rovida F; Percivalle E; Ijaz S; Dicks S; Ushiro-Lumb I; Barzon L; Siqueira P; Brown DWG; Baldanti F; Tedder R; Zambon M; de Filippis AMB; Harris E; Corti D
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8384-8389. PubMed ID: 28716913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological evidence of DENV, JEV, and ZIKV among the indigenous people (Orang Asli) of Peninsular Malaysia.
    Khor CS; Mohd-Rahim NF; Hassan H; Tan KK; Zainal N; Teoh BT; Sam SS; Khoo JJ; Lee HY; Lim YA; Abubakar S
    J Med Virol; 2020 Aug; 92(8):956-962. PubMed ID: 31814135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting the impacts of humidity, rainfall, temperature, and season on chikungunya, dengue and Zika viruses in Aedes albopictus mosquitoes from selected sites in Cebu city, Philippines.
    Edillo F; Ymbong RR; Navarro AO; Cabahug MM; Saavedra K
    Virol J; 2024 Feb; 21(1):42. PubMed ID: 38360693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.